TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT03449238: Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

Sponsor: Weill Medical College of Cornell University · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 41 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$8,482,320

Rescue Site Savings

+$5,615,610

Unlock Full NCT03449238 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT03449238 Rescue Dossier →